Cargando…
Dosimetry and treatment planning of Occu-Prosta I-125 seeds for intraocular lesions
Intraocular malignant lesions are frequently encountered in clinical practice. Plaque brachytherapy represents an effective means of treatment for intraocular lesions. Recently Radiopharmaceutical Division, BARC, Mumbai, has indigenously fabricated reasonable-cost I-125 sources. Here we are presenti...
Autores principales: | Chaudhari, Suresh, Deshpande, Sudesh, Anand, Vivek, De, Sandeep, Saxena, Sanjay, Dash, A., Basu, Mahua, Samant, Preetam, Kannan, V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786092/ https://www.ncbi.nlm.nih.gov/pubmed/20041047 http://dx.doi.org/10.4103/0971-6203.39419 |
Ejemplares similares
-
Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014) -
Episcleral plaque brachytherapy using ‘BARC I-125 Ocu-Prosta seeds’ in the treatment of intraocular tumors: A single-institution experience in India
por: Shah, Parag K, et al.
Publicado: (2012) -
Brachytherapy of intra ocular tumors using ‘BARC I-125 Ocu-Prosta seeds’: An Indian experience
por: Khetan, Vikas, et al.
Publicado: (2014) -
OccuCon 2023 Abstracts
Publicado: (2023) -
OccuPeak: ChIP-Seq Peak Calling Based on Internal Background Modelling
por: de Boer, Bouke A., et al.
Publicado: (2014)